Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

5.16

-0.06 (-1.15%)

At close: Jun 25, 2025, 4:00 PM

5.14

-0.02 (-0.39%)

Pre-market: Jun 26, 2025, 6:35 AM EDT

Recursion Pharmaceuticals Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Operating	59.82M	58.49M	64.60M	48.62M	45.23M	43.88M	46.93M	49.88M
Operating Growth	32.24%	33.30%	37.66%	-2.52%	-2.76%	10.57%	64.63%	177.85%
Grant	-25.00K	351.00K	-	1.01M	1.00M	699.00K	432.00K	1.11K
Grant Growth	-	-49.79%	-	91,498.92%	-	-	390.31%	-99.09%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.